FLSM
Frazier Life Sciences Management’s Rhythm Pharmaceuticals RYTM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-678,760
| Closed | -$36M | – | 54 |
|
|
2025
Q1 | $36M | Sell |
678,760
-1,191,048
| -64% | -$63.1M | 1.64% | 14 |
|
|
2024
Q4 | $105M | Sell |
1,869,808
-547,144
| -23% | -$30.6M | 4.34% | 8 |
|
|
2024
Q3 | $127M | Buy |
2,416,952
+45,648
| +2% | +$2.39M | 5.08% | 6 |
|
|
2024
Q2 | $97.4M | Buy |
2,371,304
+181,125
| +8% | +$7.44M | 4.55% | 6 |
|
|
2024
Q1 | $94.9M | Sell |
2,190,179
-181,125
| -8% | -$7.85M | 4% | 8 |
|
|
2023
Q4 | $109M | Hold |
2,371,304
| – | – | 5.83% | 6 |
|
|
2023
Q3 | $54.4M | Buy |
2,371,304
+204,082
| +9% | +$4.68M | 3.61% | 8 |
|
|
2023
Q2 | $35.7M | Buy |
2,167,222
+2,483
| +0.1% | +$40.9K | 2.13% | 11 |
|
|
2023
Q1 | $38.6M | Buy |
2,164,739
+270,739
| +14% | +$4.83M | 2.8% | 11 |
|
|
2022
Q4 | $55.2M | Hold |
1,894,000
| – | – | 3.43% | 12 |
|
|
2022
Q3 | $46.4M | Buy |
+1,894,000
| New | +$46.4M | 3.57% | 8 |
|